Furthermore, the dipeptidyl peptidase-4 inhibitor linagliptin can inhibit TGF-β2-induced EndMT via microRNA 29a and act as an antifibrotic in DKD [41]. The gene discussed is DPP4; the disease is diabetic kidney disease.